Loading clinical trials...
Loading clinical trials...
Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.
Conditions
Interventions
Propranolol and Etodolac
Locations
3
Israel
Rabin- Beilinson Medical Center
Petah Tikva, Israel
Tel Aviv-Sourasky Medical Center
Tal Aviv, Israel
Sheba Medical Center
Tel Litwinsky, Israel
Start Date
January 1, 2010
Primary Completion Date
January 1, 2017
Completion Date
January 1, 2017
Last Updated
July 12, 2011
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
Sheba Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions